Details for New Drug Application (NDA): 006800
✉ Email this page to a colleague
NDA 006800 describes PARADIONE, which is a drug marketed by Abbvie and is included in one NDA. Additional details are available on the PARADIONE profile page.
The generic ingredient in PARADIONE is paramethadione. Additional details are available on the paramethadione profile page.
The generic ingredient in PARADIONE is paramethadione. Additional details are available on the paramethadione profile page.
Summary for 006800
| Tradename: | PARADIONE |
| Applicant: | Abbvie |
| Ingredient: | paramethadione |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 300MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
